ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Protocols Approved During The Month of September 2001

October 26, 2001

Duke Officials Decline To Provide Details Of Probe

July 23, 2010

NCI “Community Cancer Centers” Program in Development, House Report Reveals.

June 30, 2006

New Treatment Approach To Treating Brain Tumor

April 26, 2002

In Brief: Hopkins Gets $10 Million for Directorships, to Dedicate New Clinical Cancer Building

October 22, 1999

In Breif: Folkman selected For Karnofsky Lecture; Sporn to give ACS Lecture At ASCO

February 2, 1996